logo
New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration

New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration

Business Wire27-05-2025
SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister's visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development.
Novotech, a leading global CRO trusted by biotech and mid-sized pharma to guide drug development, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19.
Share
'Novotech is a fantastic success story demonstrating the global value of NSW's strengths in life sciences and clinical trials,' said Minister Chanthivong. 'I was thrilled to learn about Novotech's growth in the Republic of Korea and the central role their business plays in bringing Korean biotech innovation to the world. Investment NSW looks forward to continuing to support Novotech as it generates export dollars for our state while helping people around the world tackle serious health issues.'
Minister Chanthivong was joined by a delegation including:
Brooke O'Rourke, Chief of Staff to Minister Chanthivong.
Rebecca McPhee, Deputy Secretary of Investment NSW.
David Lawson, NSW Trade & Investment Commissioner for Japan & Korea.
Yoojin Kim, NSW Trade & Investment Director for Korea.
The delegation engaged with Novotech leaders Dr. Yooni Kim, Hyun Kim, and Lilian Kim, who shared insights into Novotech's growth as a global clinical research organization and the expanding role of South Korea as a premier destination for clinical trials.
'We are honored that the Australian NSW Trade Minister and senior officials from NSW Investment have selected Novotech as a leading example of collaboration between Australia and South Korea,' said Dr. Yooni Kim, Managing Director – Asia-Pacific at Novotech. 'This visit reinforces the strong and growing partnership between the two countries in the clinical research and biopharmaceutical sector. As the largest Australian-founded global services company operating in South Korea, Novotech is committed to creating more success stories that demonstrate the value of this collaboration. I believe Novotech's strong partnership with the Australian NSW government and their NSW Investment can mutually benefit Korean biotech companies and the Australian clinical trial market.'
The discussion reinforced Novotech's strong partnership with Australia, supported by a track record of successful clinical trials and a shared vision for future innovation. With increasing interest from Korean biotechs to conduct research in Australia, both parties explored opportunities to enhance bilateral cooperation and accelerate cross-border clinical development.
Novotech, recently recognized as the Best CRO in Australia by IMAPAC's Asia-Pacific Biopharma Excellence Awards, continues to solidify its position as the region's leading clinical development partner. The company offers Korean biotech sponsors seamless access to Australia's world-class research infrastructure, regulatory expertise, and accelerated clinical pathways. Through its integrated full-service model, Novotech enables Korean biotechs to confidently expand early-phase programs into Australia, backed by deep regional knowledge and globally aligned operational standards.
About Novotech Novotech-CRO.com
Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase.
With a global footprint that includes 30+ offices across the Asia-Pacific region, North America, and Europe and partnerships with 5,000+ trial sites, Novotech provides clients an accelerated path to bring life-changing therapies to market by providing access to key clinical trial destinations and diverse patient populations.
Through its client-centric service model, Novotech seamlessly integrates people, processes, and technologies to deliver customized solutions that accelerate the path to market for life-changing therapies. By adopting a true partnership approach, Novotech shares a steadfast commitment to client success, empowering innovation, and advancing healthcare worldwide.
Recipient of numerous industry accolades, including the Frost & Sullivan CRO Company of the Year award for 19 consecutive years, Novotech is recognized for its excellence in clinical trial execution and innovation. Its deep therapeutic and regulatory expertise, combined with local market insights, ensures streamlined clinical trials, optimized data analytics, and accelerated patient recruitment strategies.
Together with clients, Novotech transforms scientific advancements into therapies that improve global health outcomes, embodying a mission of driving innovation and delivering impactful results
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

RollsPack launches new manufacturing facility in Huai'an, China
RollsPack launches new manufacturing facility in Huai'an, China

Yahoo

time16 minutes ago

  • Yahoo

RollsPack launches new manufacturing facility in Huai'an, China

RollsPack has launched Rolls Technology, a new manufacturing facility situated in Huai'an, China, aimed at expanding the company's footprint in global markets. This strategic move is set to provide sustainable packaging solutions to various sectors, including food and e-commerce. Spanning 53ha, the new Rolls Technology site features an 18,400m² production plant equipped with advanced clean-room environments and machinery such as BOBST-branded presses and laminators. The facility aims to set a new standard in hygiene and quality, meeting the highest global standards. RollsPack's investment in Rolls Technology is expected to offer clients improved quality control, faster lead times, and a level of product consistency that is essential in competitive markets. The company noted that the collaboration between Australian and Chinese teams at Rolls Technology demonstrates a cross-border effort to merge expertise and innovation. Environmental sustainability was a key focus during the development of Rolls Technology. The facility is designed to minimise emissions and incorporate sustainable manufacturing practices, aligning with RollsPack's goal to build an environmentally friendly future in flexible packaging. Rolls Technology is positioned to serve customers not only in China but also in Australia, New Zealand, and other international markets. The facility is expected to provide reliability in supply chains, even amidst market volatility. RollsPack said in a statement: 'The opening of Rolls Technology represents an exciting new chapter in the RollsPack group story. It's a symbol of growth, innovation and the relentless pursuit of excellence. We're incredibly proud of what our team has accomplished and even more excited for what's ahead.' "RollsPack launches new manufacturing facility in Huai'an, China" was originally created and published by Packaging Gateway, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Se produjo un error al recuperar la información Inicia sesión para acceder a tu portafolio Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información

Seoul Takes Over Paris – Seoul Design Foundation Sets the Global Stage at Maison&Objet Paris
Seoul Takes Over Paris – Seoul Design Foundation Sets the Global Stage at Maison&Objet Paris

Business Wire

time2 hours ago

  • Business Wire

Seoul Takes Over Paris – Seoul Design Foundation Sets the Global Stage at Maison&Objet Paris

SEOUL, South Korea--(BUSINESS WIRE)--The soul of Seoul is heading to Paris—and it's not coming quietly. From September 4 to 8, 2025, the Seoul Design Foundation (SDF) will make a bold entrance at Maison&Objet Paris, one of the world's top three design fairs, accompanied by 20 of the city's most innovative design brands. Under the evocative slogan 'Seoul My Soul,' this exhibition will not only highlight Seoul's rich heritage and cutting-edge design but also stake its claim as a global creative powerhouse. This isn't just an exhibition—it's Seoul's declaration of design identity to the world. Through this participation, the Foundation aims to enhance Seoul's global design presence and communicate the city's creative potential, cultural depth, and technical innovation to a broader audience. Share The Seoul pavilion will be located in Hall 7, Gift & Play section, occupying approximately 180 square meters. Visitors will encounter a wide spectrum of creative works, ranging from trend-forward lifestyle products to reimagined traditional crafts and eco-conscious design pieces that address both current needs and future directions. Participating brands are grouped under three thematic categories. The Living Trend section features 8 brands offering lighting, compact storage furniture, eco-friendly kitchenware, and stylish bathroom accessories—products that embody Seoul's current lifestyle sensibilities and are already gaining popularity both online and offline. The Contemporary Interpretation of Tradition section includes 5 brands that transform traditional Korean materials—such as hanji (paper leather), mosi (ramie), najeon (mother-of-pearl), and embroidery—into modern interior objects and fashion items, bridging cultural heritage with contemporary aesthetics. The Sustainable Design section introduces 7 brands showcasing recycled textile bags, paper leather pouches, eco-activewear, and mindful kitchen items. These products represent the embodiment of Seoul's urban sustainability philosophy, where environmental responsibility meets design excellence. Beyond simply organizing an exhibition, the Seoul Design Foundation provides comprehensive support for participating brands to expand globally. This includes everything from pre-show preparation, booth construction, on-site interpreting, logistics, buyer engagement, and marketing to post-show consultations and export support—helping these companies build sustainable momentum in the international marketplace. Through this participation, the Foundation aims to enhance Seoul's global design presence and communicate the city's creative potential, cultural depth, and technical innovation to a broader audience. The booth will also feature Seoul-themed goods developed by the Foundation, offering visitors a friendly and memorable introduction to the Seoul brand. Since its establishment in 2009, the Seoul Design Foundation has served as a key institution supporting the city's design ecosystem through the Dongdaemun Design Plaza (DDP). It continues to foster creative talent, promote local businesses, and expand global networks—solidifying Seoul's reputation as a leading city of design and innovation.

Miami Spice 2025: Dine at Michelin-starred restaurants for $35
Miami Spice 2025: Dine at Michelin-starred restaurants for $35

Axios

time2 hours ago

  • Axios

Miami Spice 2025: Dine at Michelin-starred restaurants for $35

Frugal foodies, rejoice. Miami Spice returns next week. Why it matters: The summer restaurant discount program gives diners a chance to eat Michelin-starred meals at budget-friendly prices — while supporting local restaurants during their off-season. 🤑 How it works: Running from Aug. 1-Sept. 30, Miami Spice Restaurant Months features over 300 local restaurants. Order prix fixe, three-course meals for $35 each for lunch or brunch and $45-$60 each for dinner. (Drinks, taxes and gratuity not included.) Each menu comes with an appetizer, entree and dessert. Just remember to ask your waiter for the Miami Spice menu specifically. To qualify, restaurants must offer 30% savings off their regular menu, per the Greater Miami Convention & Visitors Bureau, which organizes the annual program. ⭐️ Notable restaurants participating: The list includes Michelin-starred restaurants Cote Miami, Le Jardinier Miami and Stubborn Seed. Cote, the acclaimed Korean steakhouse in the Design District, is offering a $35 lunch Monday-Friday. Le Jardinier, also in the Design District, is offering $35 lunch and $60 dinner Tuesday-Sunday. Stubborn Seed, located in South of Fifth, is serving $60 dinner Monday-Thursday and Sunday. Nobu Miami, the high-end sushi restaurant in Miami Beach, is offering a $60 dinner Monday-Thursday and Sunday. Joe's Stone Crab Restaurant in South of Fifth is offering $35 lunch and $60 dinner on varying days. The intrigue: Some of the most audacious restaurants in Miami are lowering their prices for Miami Spice, including Papi Steak, (in)famous for serving a $1,000 steak in a gold briefcase. $60 will get you a 6-oz filet mignon (probably just on a regular plate). ❤️ More restaurants we love: 😋 Restaurants we want to try:

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store